A
ARE
Alexandria Real Estate Equities, Inc.
$41.50
Current Price
1W
1M
3M
6M
1Y
All
AI analysis
Read what the AI thinks of Alexandria Real Estate Equities, Inc. in the app.
Analyses are generated by AI from public data and are not investment advice.
Get the app
Key figures
Dividend per share
$1.96
Yield
4.72%
EPS
-$6.02
P/E
—
Data as of Oct 1
Why it matters for the long term
Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.
Upcoming events
Dividend payment
$0.72 per share
Oct 15
Quarterly earnings
Expected EPS: -$0.03
Oct 26
Posts
No posts about ARE yet.
About Alexandria Real Estate Equities, Inc.
Alexandria Real Estate Equities owns and leases office and laboratory buildings to life science companies, such as drug developers and biotech firms. It clusters its properties in research hubs like Boston, San Francisco and San Diego. It earns money from rent paid by those tenants, and it pays out much of its income to shareholders as dividends, as real estate investment trusts (REITs) do.